Eli Lilly To Acquire Biopharmaceutical Company In $3.2B Deal
Eli Lilly to Acquire Morphic Holding for $3.2 Billion.
Disclaimer: This article is intended for informational purposes only and does not constitute financial or medical advice. All the information provided is based on publicly available sources as of the date of writing.
Real-time information is available daily at https://stockregion.net